Disclosure statement
Kendra Sweet: Consultancy, Honoraria, Membership on an entity’s Board of Directors or advisory committees for: Mablytics, AROG, Astellas, Curis, Pfizer, Bristol Myers Squibb, Syntrix Pharmaceuticals, Novartis, Gilead Inc, berGenBio.